Top

Published in:

Open Access 01-12-2020 | RESPIRATORY DISEASES

Early life exposures and risk of adult respiratory disease during 50 years of follow-up

Authors: Carl J. Johansson, Peter M. Nilsson, Claes Ignell

Published in: European Journal of Epidemiology | Issue 12/2020

Abstract

Adult health is influenced by factors during fetal life affecting organ development and birth weight. We aimed to study such factors in relation to adult respiratory disease (ARD) risk. The Helsingborg Birth Cohort, Sweden, contributed baseline data collected by medical staff through clinical examination and questionnaires on maternal and birth characteristics 1964–1967. Register linkages were performed with completions of data on ARD by ICD 8–10 classifications (1969–2016), and/or ARD-related drug usage (2005–2016) enabling a 50-year follow-up time. Cox proportional hazard regression analyses were made to adjust for potential confounders, adjusted hazard ratio (aHR). A total of 3675 mothers and their offspring were included. Female offspring showed higher frequency of ARD than males, aHR 1.5 (95% CI 1.3–1.8). Maternal use of sedatives during second trimester, aHR 2.2 (95% CI 1.4–3.4), and maternal smoking during most of pregnancy, aHR 1.2 (95% CI 1.0–1.4), were associated with offspring ARD. Stratified by sex, large-for-gestational-age, aHR 1.4 (95% CI 1.0–1.9), was significantly associated with ARD in female offspring along with maternal sedative use during second trimester and maternal smoking during most of pregnancy. Maternal sedative use during second trimester or all trimesters were the only significant risk factors for male offspring. In conclusion, maternal sedative use in second trimester was independently associated with subsequent respiratory disease in adult offspring irrespective of sex.

Available only for authorised users

Xie M, Liu X, Cao X, Guo M, Li X. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020;21(1):49.PubMedPubMedCentral

López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23.PubMed

Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1(8489):1077–81.PubMed

Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2(8663):577–80.PubMed

Law CM, Barker DJP. Fetal influences on blood pressure. J Hypertens. 1994;12:1329–32.PubMed

Barker DJP, Godfrey KM, Fall C, et al. Relation of birthweight and childhood respiratory infection to adult lung function and death from chronic airways disease. In: Barker DJP, editor. Fetal and infant origins of adult disease. 1st ed. London: BMJ; 1992. p. 150–61.

Barker DJP, Osmond C, Law CM. Intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. In: Barker DJP, editor. Fetal and infant origins of adult disease. 1st ed. London: BMJ; 1992. p. 62–7.

Barker DJP. Intrauterine origins of cardiovascular and obstructive lung disease in adult life. In: Barker DJP, editor. Fetal and infant origins of adult disease. 1st ed. London: BMJ; 1992. p. 231–8.

Broström EB, Akre O, Katz-Salamon M, Jaraj D, Kaijser M. Obstructive pulmonary disease in old age among individuals born preterm. Eur J Epidemiol. 2013;28(1):79–85.PubMed

10.

Lawlor DA, Ebrahim S, Davey Smith V. Association of birth weight with adult lung function: findings from the British Women’s Heart and Health Study and a meta-analysis. Thorax. 2005;60(10):851–8.PubMedPubMedCentral

11.

Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. Associations between birth weight, early childhood weight gain and adult lung function. Thorax. 2009;64(3):228–32.PubMed

12.

Canoy D, Pekkanen J, Elliott P, Pouta A, Laitinen J, Hartikainen AL, et al. Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax. 2007;62:396–402.PubMed

13.

Mu M, Ye S, Bai MJ, Liu GL, Tong Y, Wang SF, et al. Birth weight and subsequent risk of asthma: a systematic review and meta-analysis. Heart Lung Circ. 2014;23(6):511–9.PubMed

14.

Briana DD, Malamitsi-Puchner A. Small for gestational age birth weight: impact on lung structure and function. Paediatr Respir Rev. 2013;14(4):256–62.PubMed

15.

Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 2014;94(4):1027–76.PubMedPubMedCentral

16.

Nilsson PM, Hofvendahl S, Hofvendahl E, Brandt L, Ekbom A. Smoking in pregnancy in relation to gender and adult mortality risk in offspring: the Helsingborg Birth Cohort Study. Scand J Public Health. 2006;34(6):660–4.PubMed

17.

Palmgren B, Wahlén T, Wallander B. Toxemia and cigarette smoking during pregnancy. Prospecitve consecutive investigation of 3927 pregnancies. Acta Obstet Gynecol Scand. 1973;52(2):183–5.PubMed

18.

Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85(7):843–8.PubMed

19.

Chung WS, Lai CY, Lin CL, Kao CH. Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study. Medicine (Baltimore). 2015;94(27):e1110.

20.

Nakafero G, Sanders RD, Nguyen-Van-Tam JS, Myles PR. Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. 2015;24(8):793–802.PubMed

21.

Baillargeon J, Singh G, Kuo YG, Raji MA, Westra J, Sharma G. Association of opiod and benzodiazepine use with adverse respiratory events in older adults with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(10):1245–51.PubMedPubMedCentral

22.

López-Munoz F, Ucha-Udabe R, Álamo C. The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat. 2005;1:329–43.PubMedPubMedCentral

23.

López-Muñoz F, Alamo C, García-García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs. J Anxiety Disord. 2011;25:554–62.PubMed

24.

Tomson T, Battino D, Bonizzoni E, Lindhout D, Sabers A, Perucca E, Vajda F, EURAP Study Group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10:609–17.PubMed

25.

Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, Nakane Y, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res. 1999;33:145–58.PubMed

26.

Browne ML, Van Zutphen AR, Botto LD, Louik C, Richardson S, Druschel CM. Maternal butalbital use and selected defects in the national birth defects prevention study. Headache. 2014;357:54–66.

27.

Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv. 2002;53:39–49.PubMed

28.

Wikner BN, Stiller C-O, Bergman U, Asker C, Källén B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16:1203–10.PubMed

29.

Kotecha S. Lung growth for beginners. Paediatr Respir Rev. 2000;1:308–13.PubMed

30.

Wigglesworth JS. Lung development in the second trimester. Br Med Bull. 1988;44:894–908.PubMed

31.

Leynaert B, Sunyer J, Garcia-Esteban R, Svanes C, Jarvis D, Cerveri I, et al. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort. Thorax. 2012;67(7):625–31.PubMed

32.

Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an up-date. Transl Res. 2013;162:208–18.PubMed

33.

Sin DD, Spier S, Svenson LW, Schopflocher DP, Senthilselvan A, Cowie RL, et al. The relationship between birth weight and childhood asthma: a population-based cohort study. Arch Pediatr Adolesc Med. 2004;158(1):60–4.PubMed

34.

Hancox RJ, Milne BJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, et al. Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. Am J Respir Crit Care Med. 2005;171:440–5.PubMed

35.

Baker JL, Olsen LW, Sørensen TIA. Weight at birth and all-cause mortality in adulthood. Epidemiology. 2008;19:197–203.PubMed

36.

Landau LI. Tobacco smoke exposure and tracking of lung function into adult life. Paediatr Respir Rev. 2008;1:39–43.

37.

Beyer D, Mitfessel H, Gillissen A. Maternal smoking promotes chronic obstructive lung disease in the offspring as adults. Eur J Med Res. 2009;14(4):27–31.PubMedPubMedCentral

38.

Hayatbakhsh MR, Sadasivam S, Mamun AA, Najman JM, Williams GM, O’Callaghan MJ. Maternal smoking during and after pregnancy and lung function in early adulthood: a prospective study. Thorax. 2009;64(9):810–4.PubMed

39.

Savran O, Ulrik CS. Early life insults as determinants of chronic obstructive pulmonary disease in adult life. Int J Chronic Obstr Pulm Dis. 2018;13:683–93.

40.

Horta BL, Victora CG, Menezes AM, Halpern R, Barros FC. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol. 1997;11(2):140–51.PubMed

41.

Ko TJ, Tsai LY, Chu LC, Yeh SJ, Leung C, Chen CY, et al. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatr Neonatol. 2014;55(1):20–7.PubMed

42.

Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93(5):351–61.

43.

Crane JM, Keough M, Murphy P, Burrage L, Hutchens D. Effects of environmental tobacco smoke on perinatal outcomes: a retrospective cohort study. BJOG. 2011;118(7):865–71.PubMed

44.

Balte P, Karmaus W, Roberts G, Kurukulaaratchy R, Mitchell F, Arshad H. Relationship between birth weight, maternal smoking during pregnancy and childhood and adolescent lung function: a path analysis. Respir Med. 2016;121:13–20.PubMedPubMedCentral

45.

Borna E, Nwaru BI, Bjerg A, Mincheva R, Rådinger M, Lundbäck B, Ekerljung L. Changes in the prevalence of asthma and respiratory symptoms in western Sweden between 2008 and 2016. Allergy. 2019;74(9):1703–15.PubMed

Title: Early life exposures and risk of adult respiratory disease during 50 years of follow-up
Authors: Carl J. Johansson
Peter M. Nilsson
Claes Ignell
Publication date: 01-12-2020
Publisher: Springer Netherlands
Published in: European Journal of Epidemiology / Issue 12/2020
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-020-00626-3

ACC 2024 Congress

Springer Medicine

Early life exposures and risk of adult respiratory disease during 50 years of follow-up

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2020

Total dietary antioxidant capacity and risk of type 2 diabetes

Body mass index and height in relation to type 2 diabetes by levels of intelligence and education in a large cohort of Danish men

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Annual rate of newly treated atrial fibrillation by age and gender in France, 2010–2016

Epidemiology is about disease in populations

A note of thanks